(2023) [13], using the same dosages of tirzepatide, showed HbA1c reductions ranging from 2.01% to 2.30%, involving 1879 patients with a mean age of 56.6 years
Greig D, Alcaino H, Castro PF, Garcia L, Verdejo HE, Navarro M, et al
Given tirzepatide shorter half-life of about 5 days, the washout window can be shorter than when switching in the other direction
Melatonin and oxidative stress in melasma - an unexplored territory
Due to an aging population and unhealthy lifestyle, the prevalence of type 2 diabetes is expected to increase steadily over the next few years
Prescriptions for weight loss and T2D continue trending upward